The Supreme Court unanimously ruled on Tuesday that medical tests that rely on correlations between drug dosages and treatment are not eligible for patent protection. Writing for the court, Justice Stephen G. Breyer said natural laws may not be patented standing alone or in connection with processes that involve “well-understood, routine, conventional activity.”